Aoxin Q&M Dental Group Ltd. (SG:1D4) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Aoxin Q&M Dental Group Ltd. reports on the strategic review of its associated company Acumen, following the expiration of its Laboratory Licence and the pending closure of the Sengkang Joint Testing and Vaccination Centre. Acumen’s profitability has been maintained by a government contract for COVID-19 vaccinations, despite financial losses in its non-COVID testing operations. The cessation of these operations highlights potential challenges for investors as the company navigates future business strategies.
For further insights into SG:1D4 stock, check out TipRanks’ Stock Analysis page.